Wordt geladen...
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
Background: Mood disorders represent a risk factor for dementia and are present in over 60% of cases with Alzheimer’s disease (AD). More than 80% variability in drug pharmacokinetics and pharmacodynamics is associated with pharmacogenetics. Methods: Anxiety and depression symptoms were assessed in 1...
Bewaard in:
| Gepubliceerd in: | Pharmaceuticals (Basel) |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8071277/ https://ncbi.nlm.nih.gov/pubmed/33920985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040366 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|